An Open-Label Clinical Study Evaluating the Long-Term Safety of ALTU-135 Treatment of Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
|Effective start/end date
|5/2/07 → 12/31/08
- ALTUS PHARMACEUTICALS INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.